Adverse Drug Reactions - Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
Adverse Drug Reactions - Neurogen Proprietary Insomnia Compound Data for Two Studies Presented at Associated Professional Sleep Societies Annual Meeting
Adverse Drug Reactions - Safety Measures for Oseltamivir Phosphate and Chugai's Future Approach
Agilent Technologies Inc. - Agilent Technologies Expands Informatics Portfolio with Electronic Notebook for Life Sciences, Chemical Analysis After Acquiring Kalabie from Klee Group
Alexion Pharmaceuticals - Alexion To Present At the William Blair 27th Annual Growth Stock Conference
Algonomics - Investment boosting the Epibase immunogenicity screening services.
AlgoNomics NV - AlgoNomics To Raise 1.5 million Euro
Aneurysm - NeuroVasx, Inc. Announces 510(k) FDA Submission of its cPAX Aneurysm Treatment System for Treatment of Cerebral Aneurysms
Angina - Ranbaxy Receives Tentative Approval to Manufacture and Market Amlodipine Besylate Tablets
Angiogenesis - CardioVascular BioTherapeutics to Present at Euro-Biotech Forum
Angiogenesis - Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
Angiotensins - Exforge Receives Final US Approval as New and Powerful Treatment Option for Patients With High Blood Pressure
Angiotensins - Keryx Biopharmaceuticals Announces Completion of Patient Randomization Into Sulonex Phase III Pivotal Study
Ankylosing Spondylitis - Remicade Two Year Data In Ankylosing Spondylitis Show Improvement In Spinal Mobility and Spinal Inflammation
Anti-Infectives - Partnering strategy for DSM Anti-Infectives
Antibiotics - Murray's Chicken Congratulates Tyson Foods, Inc. on Today's Announcements That all of Their Fresh Chickens will be Raised Without Antibiotics
Arthritis - ACTEMRA (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
Arthritis - Actemra: Roche's novel rheumatoid arthritis drug shows substantial benefits for patients in OPTION study
Arthritis - Genzyme Files for Approval of Single-Treatment Synvisc-One
Arthritis - GlaxoSmithKline and Genmab Present Positive Phase II Results With ofatumumab in Patients With Rheumatoid Arthritis (RA)
Arthritis - GlaxoSmithKlline and Genmab present positive Phase II results with ofatumumab in patients with rheumatoid arthritis (RA)
Arthritis - Ibex Reports Fiscal 2007 Third Quarter Results
Arthritis - Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
Arthritis - Oryx Pharmaceuticals Announces Launch of Naprelantm
Arthritis - Prexige study shows significantly less impact on blood pressure than ibuprofen in osteoarthritis patients with controlled hypertension
Asthma - Adenosine Therapeutics Announces Investment by Novartis Option Fund and Option Agreement to Develop Novel Oral Drugs for Diabetes and Asthma
Asthma - Next Safety, Inc.'s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
Attention Deficit Hyperactivity Disorder - Shire Receives Approvable Letter From FDA for INTUNIV (guanfacine) Extended Release, a Nonstimulant for the Treatment of ADHD
Biotech Business - New Life Sciences Campus in Worcester Will Advance Massachusetts' Position as Biotech Leader
Biotech Business - Stem Cell Sciences In-Licenses Breakthrough Discovery for the Production of Human Stem Cells (''Stem Cell Sciences'', ''SCS'' RIG
Biotechnology - InNexus Named to Top 50 of TSX Venture Exchange
Biotechnology - Taconic Announces New Vice President of Operations
Bird Flu - Former President and CEO of Biomira Alex McPherson Joins Carrington Board of Directors
Bird Flu - Ludlow China Upgrades China Biopharma, Inc.
Blood Glucose - ARKRAY USA Launches Assure 4 Blood Glucose Monitoring System
Borean Pharma ApS - Borean to Present at the 14th Annual Euro-Biotech Forum, June 26-28 in Paris
Breast Cancer - Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
Breast Cancer - Breast Cancer Treatment Reduces Radiation Therapy from Weeks to Days
Breast Cancer - BSD Medical Files Patent for New 'Smart Weapon' Applicator to Trigger 'Smart Bomb' Delivery of Chemotherapy in Breast Tumors
Breast Cancer - Genesis Bioventures Announces Breast Cancer Marker Granted European Diagnostic and Therapeutic Patent Approval
Breast Cancer - Lack of Available Patients for Testing Limits Development of Breast Cancer Drugs
Bristol-Myers Squibb - Statement on the Deferred Prosecution Agreement Following Press Release From U.S. Attorney
Cachexia - Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
Cancer - OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
Cancer - Plexxikon Expands Management Team and Board of Directors
Cancer - S*BIO Becomes Singapore's First Biotech Company To Initiate Clinical Trial of Novel Anti-Cancer Drug
Cancer - Scientists Discover New Role for MicroRNAs in Stopping Tumor Cell Growth
Cancer - There Are Currently More Than 400 Antibody Based Drugs in Development for the Treatment of Cancer
Cancer - Varian Medical Systems Names C. Clifton Ling as Director of Advanced Clinical Research
Cancer - Vicus Therapeutics to Present Results from Investigator-led Cancer Cachexia Studies at the 12th Congress of the Japanese Society for Palliative Medicine
Cancer Vaccines - Accentia Biopharmaceuticals' Majority-Owned Subsidiary, Biovest, Receives Request From the Independent Data Monitoring Committee to Conduct Interim Analysis of Anti-Cancer Vaccine, BiovaxID
Cancer Vaccines - Coley Pharmaceutical Group Announces Pfizer's Discontinuation of Clinical Trials for PF-3512676 Combined with Cytotoxic Chemotherapy in Advanced Non Small Cell Lung Cancer
Cancer Vaccines - Generex Biotechnology Awarded New U.S. Patents for Its Core Vaccine Technologies
Cancer Vaccines - Geron Increases Stake in TA Therapeutics Joint Venture
Cancer Vaccines - GlaxoSmithKline expects to launch up to five major new medicines for oncology in next three years
Cancer Vaccines - Global Summit of Women Launches Consortium to End Cervical Cancer
Cancer Vaccines - Inovio Biomedical's Selective Electrochemical Tumor Ablation Therapy Shows Safety, Tolerability, and Significant Complete Responses in Breast Cancer Study
Cancer Vaccines - Merck Provides Update on Status of Supplemental Biologics License Applications (sBLA) for GARDASIL
Cancer Vaccines - Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Geron's Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
Chemical-mechanical Planarization - Ferro Launches Two CMP Slurries, Enabling Next-Generation Technology for Leading Edge Electronics
Chronic Pain - Assured Pharmacy Signs Lease for 7th Pharmacy
Chronic Pain - Phase II Data Show Efficacy and Tolerability of Tapentadol in Chronic Pain Treatment
Circulation Research - NMT Medical's BioSTAR Receives Canadian Regulatory Approval, Commercial Launch of New Bioabsorbable Technology is Expected Early in the Third Quarter
Clinical Research - Investigators Report Stronger Relationships with Quintiles Than Any Other CRO
Clinical Trial Research - Accentia Biopharmaceuticals, Inc. to Present at the Jefferies Healthcare Conference in New York City on June 27, 2007 at 9:40AM/ET
Clinical Trial Research - Neurochem receives third recommendation from European Data Safety Monitoring Board to continue Phase III clinical trial for tramiprosate (ALZHEMED)
Clinical Trial Research - Novo Nordisk and Neose announce initiation of phase 1 clinical trial of long-acting factor VIIa
Clinical Trial Research - Novo Nordisk and Neose Announce Initiation of Phase I Clinical Trial of Long-Acting Factor VIIa
Clinical Trial Research - Othera Pharmaceuticals and the National Eye Institute Reach Target Enrollment in Dry AMD Clinical Trial with OT-551 Eye Drops
Clinical Trial Research - PHT Announces Exclusive ePRO Products at DIA 2007 while Celebrating 300 eDiary Clinical Trials
CollaGenex Pharmaceuticals, Inc. - CollaGenex Pharmaceuticals to Present at the 17th Annual Wachovia Nantucket Equity Conference on June 27th
Colon Cancer - Abraxis BioScience Exclusively Licenses Intellectual Property Portfolio Designed to Personalize Treatment for Colorectal Cancer from the University of Southern California
CompPharma, LLC - CompPharma Established to Provide Services for Workers' Compensation Pharmacy Benefit Managers (PBMs)
Cook Medical - Cook Pharmica Names Vice Presidents
Cutting Edge Information - How Do They Stack Up? Comparing US vs. Canadian Pharmaceutical Marketing Budgets
Cutting Edge Information - Pharmaceutical Patient Education: Balancing Information and Promotion
CV Therapeutics, Inc. - CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350
Cytokines - Rexahn Pharmaceuticals, Inc. Appoints Dr. Freddie Ann Hoffman to the Board of Directors
Dementia - Merz funded Alois Alzheimer Award 2007 bestowed upon Professor Dr. Agneta Nordberg
Dermatology - Advitech Announces an Exclusive Distribution Agreement for Dermylextm To the U.s. Market
Dermatology - Auriga Laboratories Announces the Formation of A.T.S. Pharmaceuticals, a Specialty Division dedicated to Dermatology and Gastroenterology
Diabetes - Basilea Announces Submission of Marketing Authorization Application in Europe by Janssen-Cilag International NV for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Cephalosporin
Diabetes - Bio-rad's Participation In Tour De Cure In Napa Valley Helps Raise $1.12 Million
Diabetes - DexCom Appoints Terrance H. Gregg as CEO
Diabetes - Diabetes drug supported by Mexican Diabetes Federation
Diabetes - FDA Approves New Route of Administration for Rapid-Acting Apidra Providing an Additional Treatment Option for Hospitalized Diabetes Patients with High Blood Sugar Levels
Diabetes - Liraglutide Provides Significantly Better Glucose Control Than Insulin Glargine in Phase 3 Study
Diabetes - Oramed Pharmaceuticals Signs Agreement with Encorium Group to Commence Investigational New Drug Application
Diabetes - Valeritas Completes Hiring of its Initial Diabetes Sales Leadership Team for the Launch of the h-Patch Insulin Delivery System
Diagnostic Test - The In-Vitro Diagnostic Substance Manufacturing Industry's Revenue for the Year 2006 Was Approximately $11,300,000,000
DNA Research - Applied Biosystems Opens New Application Support Center
DNA Research - IdentiGEN Appoints Biotech Entrepreneur Dr. John Monahan to Board of Directors
Draeger Medical - Dr?ger strengthens Executive Board Two new members for the management team
Drug Abuse - Texas Governor Signs Budget into Law Including $2 Million That Can Be Used to Fund PROMETA Treatment Programs for Criminal Justice Program
Drug Delivery - Glide Pharma is Overall Winner of Prestigious 2007 Medical Futures Innovation Awards
Drug Delivery - PARI Pharma Presents Study Results of Sinus Delivery and Inhaled Liposomal Ciclosporin a at European Cystic Fibrosis Conference
Drug Delivery - SCOLR Pharma, Inc. Issued Fifth Drug Delivery Patent for CDT Drug Delivery Platform
Drug Development - A ONCE-WEEKLY ANTIOSTEOPOROTIC AGENT "ACTONEL 17.5 mg TABLETS" IS LAUNCHED.
Drug Development - Acura Pharmaceuticals, Inc. and FDA Reach Agreement on Special Protocol Assessment for Pivotal Phase 3 Study for OxyADF Tablets
Drug Development - Aptuit to Invest More Than $100 Million in Laurus Labs (India); Dr. Satyanarayana Chava Named Aptuit Laurus CEO, Joins Aptuit Board
Drug Development - BioMarin Initiates Expanded Access Program for Kuvan in the U.S.
Drug Development - Branded Pharmaceutical Association Submits Legacy Drug Initiative
Drug Development - Phase Forward Announces New Hosted Submission Checking Service Offering to Help Customers Submit CDISC Standards-Compliant Data to FDA
Drug Development - Piper Jaffray Second Annual London Health Care Conference to Webcast Alexza's Corporate Presentation
Drug Development - Research on New Treatment for Neglected Disease Published in the New England Journal of Medicine
Drug Development - Ryoka Systems and BiosolveIT Sign Comprehensive Distribution Contract
Drug Development - Senopsys and Patheon Collaborate to Develop Palatable Drug Products
Drug Development - Sex, Drugs and Alcohol Popular with Some Teens on Online Message Boards
Drug Development - Simulations Plus Wins Small Business Innovation Research (SBIR) Grant
Drug Development - Synosia Therapeutics Announces Appointment of Vice President of Regulatory Affairs
Drug Development - The European Commission suggests initiatives focusing on medicinal product safety
Drug Development - The New Tripos (DE), Inc. Announces Release of Chemistry Extensions Package for Open-Source KNIME Workflow Platform
Drug Development - The Public is Doubtful that Strengthening the FDA's Oversight of the Prescription Drug Industry Will Make a Difference
Drug Development - Thermo Fisher Scientific Launches RNAi Services Laboratory Supporting Researchers in Drug Discovery and Development
Drug Development - Three New Associate Directors Join the Automation Partnership
Drug Resistance - Additional Studies Demonstrate PuriCore's Sterilox Solution Effective against Major Outbreak Pathogens
Drug Resistance - Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
Drug Resistance - CardioTech Announces Patent Filing for Antimicrobial Polymers Designed to Avoid Infections Without Using Antibiotic Drugs
Drug Resistance - Janssen-Cilag International NV Submits Marketing Authorization Application in Europe for New Antibiotic
Drug Resistance - Keep Antibiotics Working Coalition Applauds Tyson for Producing Fresh Chickens Without Antibiotics
Drug Resistance - Magellan Biosciences Companies to Feature Products Designed to Improve Health Outcomes at AACC/ASCLS Clinical Lab Expo, Booth 2647
Drug Resistance - TheraDoc's Best-in-Class Infection Control and Antimicrobial Management Solutions Enhance Strong Midwest Patient Safety Programs
Drug Safety - 'Art of Safety' Educational Exhibit Highlights Drug Safety
Drug Safety - Relsys and Sentrx Continue Partnership To Offer Hosted Argus Safety
DUSA Pharmaceuticals - DUSA Pharmaceuticals, Inc. Elects Robert F. Doman as Chief Executive Officer
Elusys Therapeutics, Inc. - Elusys Names Jeremy D. Middleton Vice President of Corporate Development
Endo Pharmaceuticals - Endo Pharmaceuticals Contributes More Than 200,000 Synera Patches To Americares
EPIC-MRA - Michigan Supports Drug Website Expansion
Epidemic - Chicago Community Leaders Come Together to Confront the Diabetes Epidemic
Epidemiology - Resurgent Health and Medical to Introduce Radius Fully-Automated Handwashing and Compliance Monitoring System at Infection Control Conference
Epidemiology - The Anti-Infectives Market Is Forecast To Expand At a CAGR of 4.8% Over the Period 2005-11
Epistaxis - King Pharmaceuticals Announces FDA Approval of Epistaxis Kit for THROMBIN-JMI
Erythropoiesis - Leading National Patient Group Urges Government Officials to Preserve Access to Erythropoiesis Stimulating Agents for Cancer Patients
ExL Pharma - Leading Pharmaceutical Communication Executives Gather to Discuss Pressing Issues at the 3rd Annual PR & Communications Summit for Pharmaceutical, Biotech and Medical Technology Companies
Financing - Genesis Bioventures Announces eFund Capital Management, LLC Becomes Active Investor and Financial Consultant for Strategic Development and Financing
Financing - Gentis, Inc. Announces the Closing of Its $10 Million Series a Preferred Financing and the First Clinical Use of Its Proprietary DiscCell Spinal Nucleus Augmentation Material
Financing - IDM Pharma to Raise $25 Million in Registered Direct Offering
Financing - Lexicon Pharmaceuticals Announces Two Agreements to Finance Long-Term Drug Development Strategy
Financing - LiveVox Secures $7.1 Million in Funding to Accelerate Market Reach and Product Innovation
Financing - Lpath Closes Second Tranche of $16.8 Million Equity Financing
Financing - Micromet Announces Definitive Agreement for $25.0 Million Private Placement
Financing - Nventa announces extension of expiry date of warrants issued in 2005 financing
Financing - Ortec Announces $8.7 Million Private Placement in Conjunction With Agreement To Exchange $43 Million Liability for $10 Million of Convertible Preferred Stock
Financing - Remedent, Inc. Announces $7 Million Private Placement Financing
Financing - Sontra Medical Corporation Closes $1,000,000 Financing
Financing - SpectraScience Appoints John Pappajohn to Board of Directors
Flu Vaccines - Development of the next generation Flu vaccines commenced
Flu Vaccines - HHS Awards Two Contracts to Expand Domestic Vaccine Manufacturing Capacity for a Potential Influenza Pandemic
Flu Vaccines - MedImmune is Awarded Contract by U.S. Department of Health and Human Services to Retrofit Manufacturing Facilities for Production of Pandemic Influenza Vaccines
Flu Vaccines - Sanofi Pasteur Supports Who Initiative for the Establishment of an H5n1 Vaccine Stockpile
Gene Therapy - Announcement of Results of Phase III Clinical Trials of HGF Gene Therapy in Japan
Gene Therapy - Baxter Signs Agreements to Evaluate TISSEEL Use With New, Innovative Therapies
Gene Therapy - Ceregene and Genzyme Announce Partnership for the Development and Commercialization of Cere-120 for Parkinson's Disease
Gene Therapy - Correction of certain information in the media relating to the offering of new shares Amsterdam Molecular Therapeutics (AMT) Holding N.V.
Gene Therapy - Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
Gene Therapy - Genzyme Awarded U.S. National Medal of Technology
Gene Therapy - Honor Given by President of the United States for Contributions to Health
Gene Therapy - PAREXEL Experts To Speak At Drug Information Association's 43rd Annual Meeting, Opening Remarks From Event Chairperson, Dr. Alberto Grignolo
Gene Therapy - Targeted Genetics Reports Inflammatory Arthritis Clinical Data at European Rheumatology Conference
Genentech, Inc. - Genentech Announces July 11 Webcast Discussion of Earnings and Other Business Results
Genetics & Genomics - deCODE genetics to Webcast Presentations at its Annual R&D Event
Genetics & Genomics - ZymoGenetics Establishes Global Collaboration With Bayer HealthCare for Development and Commercialization of Recombinant Human Thrombin
Genetics & Genomics - ZymoGenetics Will Hold Conference Call on June 19 at 8:30 a.m. Eastern Time to Discuss rThrombin Collaboration with Bayer HealthCare
Gentium - Gentium Adds Seasoned Pharmaceutical Veteran Malcolm Sweeney to Board of Directors
Gulas & Stuckey - Law Firm of Gulas & Stuckey Prepares for Next Trial Against Johnson & Johnson
Heart Attack - More than half of hypertensive patients remain uncontrolled and thus at higher risk of heart attack and stroke - telmisartan may decrease this risk.
Heart Attack - Texas Family Sues GlaxoSmithKline (GSK) Over Man's Heart Attack Death Following Avandia Use
Heart Defects - Cardica and Cook Medical Enter New Collaboration Agreement to Develop and Commercialize Closure Device for Heart Defects
Hematologic Disease - Avalon Pharmaceuticals Announces Positive Interim Results for AVN944 Phase I Trial
Hematologic Disease - Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
Hemophilia - Wyeth Pharmaceuticals Introduces Its First Training Kit to Help People With Hemophilia Learn Self-Infusion Techniques
Hemorrhoids - Bradley Pharmaceuticals Launches Peranex HC Cream
Hepatitis B Virus - Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
Hepatitis B Virus - Nabi Biopharmaceuticals Announces Creation of Biologics Business Unit & Provides Strategic Updates
Hepatitis C Virus - Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of the NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
Hepatitis C Virus - Oncolys BioPharma and Tacere Therapeutics Form Strategic Alliance to Develop RNAi Hepatitis C Drug
Herpes Zoster Virus - Encorium Group, Inc. Announces $3.8 Million Contract for Phase 2 Clinical Trial in Herpes Zoster (Shingles)
HIV/AIDS - 454 Sequencing Identifies HIV Drug Resistance at Early Stage
HIV/AIDS - Boehringer Ingelheim initiates SPRING study of Aptivus (tipranavir) in diverse group of highly treatment-experienced HIV-positive patients
HIV/AIDS - Congress to Vote on Abstinence and Foreign Aid Levels
HIV/AIDS - First Ad35-Based HIV-1 Vaccine Enters Phase I Clinical Trial at the NIH
HIV/AIDS - Medi-Cal Expands Coverage of Baseline HIV Resistance Testing
HIV/AIDS - NutraCea Announces Start of HIV/AIDS Clinical Study at Hadassah University Medical Center in Jerusalem, Israel on RiSolubles as a Supportive Therapy for HIV/AIDS Patients
HIV/AIDS - Spanish Government Contributes 1 Million Euro for AIDS Vaccine Development
HIV/AIDS Cancer - Presidio Pharmaceuticals Announces Key Executive Management Additions
Hormones - Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Women's Health Initiative Data
Hormones - Merck Serono and Ambrx to Collaborate on Development of Next Generation Growth Hormone Products
Hormones - Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoie
Human Papillomavirus - China Biopharma Reaches Agreement to Introduce a New Antiviral Drug
Huntington Disease - Avicena to Present its Huntington's Disease Clinical Program at the Huntington's Disease of America Society 22nd Annual Convention
Hyperlipidemia - Metabasis Therapeutics Announces Initiation of a Clinical Trial for MB07811, Its Novel Product Candidate for the Treatment of Hyperlipidemia
Hyperoxaluria - Altus Pharmaceuticals Submits Investigational New Drug Application to Study ALTU-237 for the Treatment for Hyperoxalurias and the Potential Prevention of Kidney Stone Formation
Hypertension - Surface Logix Commences Phase 2A Clinical Trial of SLx-2101 in Hypertension
Hypertension - U.S. Food and Drug Administration Approves Gilead's Letairis (ambrisentan) 5 mg and 10 mg Tablets for the Once-Daily Treatment of Pulmonary Arterial Hypertension (WHO Group 1) in Patients wit
Hypogonadism - Solvay Pharmaceuticals, Inc. Announces Submission of Supplemental New Drug Application for AndroGel in Male Adolescents
Imaging - Making the Complex Simple in Nanotech Research
Imaging Technology - Aurora Imaging Technology Establishes Major Asia Presence
Immunotherapy - Greer Announces New Safety Syringe Contract with Inviro Medical
Kidney Disease - Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
Lamellar Ichthyosis - Barrier Therapeutics Announces Liarozole Phase 2/3 Study Results in Lamellar Ichthyosis
Leishmaniasis - Potent possibilities for parasite attack
Leukemia - Kinex Pharmaceuticals Files Investigational New Drug Application for Novel Src Kinase Inhibitor, KX2-391
Liver Cancer - Bayer and Onyx Submit New European Marketing Authorization Application to EMEA for Nexavar to Treat Liver Cancer
Lupus - Human Genome Sciences Reports That a Phase 2 Study of Lymphostat-b Showed Significant Reductions In Disease Activity In Patients With Active Systemic Lupus Erythematosus
Macular Degeneration - Advanced Cell Technology Announces Critical Advancements in Its RPE Program for the Treatment of Macular Degeneration and Other Retinal Degenerative Diseases
Malaria - Immtech Completes Dosing Protocol of Malaria Prevention Trial
Malaria - US FDA Grants Orphan Drug Status to Immtech
Managed Care - Top Pharma Companies Expand Pharmacoeconomics Departments' Reach
MAP Pharmaceuticals, Inc. - MAP Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
Marketing and Licensing Agreements - Empire Energy Subsidiary Signs Exclusive License to Supply China Dairy and Agricultural Markets with Water Purification Technology
Marketing and Licensing Agreements - KCI Enters into Exclusive Worldwide License with NovaBay for NeutroPhase Wound Treatment Solution Technology
Marketing and Licensing Agreements - Montel Williams and LifeVantage Corporation Sign License Agreement to Promote Science-Based Dietary Supplement Products
Marketing and Licensing Agreements - PhytoLabs Inc. Announces Signing of Sub-License Agreements to Distribute New Immune Product in Denmark and Finland
Marketing and Licensing Agreements - Proteros biostructures Announce Successful Achievement of Milestone in Fragment-Based Protein Crystallography Collaboration
Medicare and Medicaid - As Timeline for Demise of Community Pharmacies Is Released National Community Pharmacists Association Continues to Fight Back
Medicare and Medicaid - Gov. Perry Joins HHS Secretary Leavitt to Sign Landmark Medicaid Reform
Medicare and Medicaid - NACDS Calls for Swift Action to Fix Medicaid Prescription Reimbursement Issue in Wake of New Independent Report
Medicare and Medicaid - Office of Inspector General Report Confirms Devastating Impact of Pending Changes to Medicaid Pharmacy Reimbursement
Medicare and Medicaid - Sepracor Issues Statement Regarding CMS Medicare Part B Reimbursement Change for XOPENEX Inhalation Solution
Medicare and Medicaid - Verispan Reports: Biotech Companies Cut Sales Forces, but Managed Care Execs Want More Contact
MedImmune, Inc. - MedImmune Founder, Wayne T. Hockmeyer, Ph.D., Retires
MedImmune, Inc. - MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Convertible Senior Notes Due 2013
Menopause - Depomed Initiates Dosing of Patients In Phase 2 Trial for Gabapentin Gr for the Treatment of Menopausal Hot Flashes
Menopause - Estrogen Use Lowered One Risk Factor for Heart Disease among Some Younger Postmenopausal Women, Stanford Researcher Says
Menopause - New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
Menopause - New WHI Data Show That Women Aged 50-59 Taking Oral Estrogen Therapy Had Reduced Levels of Coronary Artery Calcification -- a Predictor of Cardiovascular Events
Menopause - New, Effective Low Dose Estrogen Therapy Introduced to National Media
Merck & Co., Inc. - Merck to Hold Second-Quarter 2007 Sales and Earnings Conference Call and Web Cast on July 23
Monoclonal Antibodies - Overseas Phase III Trial Data Demonstrates Efficacy of "Actemra," a Humanized Anti-Human IL-6 Receptor Monoclonal Antibody, in Rheumatoid Arthritis Patients
Monoclonal Antibodies - Three Studies Suggest Abbott's HUMIRA (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Movement Disorders - Solstice Neurosciences Presents Escalating Dose Study at International Congress in Istanbul, Turkey
Multiple Sclerosis - Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
Multiple Sclerosis - TNO protein offers the prospect of a potential drug to combat Multiple Sclerosis
Myelodysplastic Syndrome - Lorus Therapeutics announces the initiation of a clinical trial of GTI-2040 in acute leukemia and myelodysplastic syndrome
Myeloma - REVLIMID Granted Full Marketing Authorization for Treatment of Multiple Myeloma in the European Union
Myeloma - The International Myeloma Foundation Says EMEA Marketing Approval of REVLIMID is an Important Advance for Patients in Europe
Myeloma - VELCADE (bortezomib) for Injection Survival Data in Front-Line Multiple Myeloma Patients to be Featured at 11th International Myeloma Workshop
Nanotechnology - MDMA Voices Concerns Over the Patent Reform Act of 2007: Bill Will Stifle Innovation and Investment
Natural Nutrition, Inc. - Natural Nutrition Subsidiary Interactive Nutrition Posts Record Sales in May
Neurology - Kendle Strengthens Regulatory Consulting Expertise Through Key Appointments
Neutropenia - St. Jude Shows Gene Test Not Needed If Cancer Drug Given in Low Dose
NexMed, Inc. - NexMed Appoints Vivian Liu as Chief Executive Officer
Non-Small Cell Lung Cancer - Uptake of Avastin and New Agents from ImClone/Merck Serono, AstraZeneca, and Bayer/Onyx Will Drive Robust Near-Term Growth in the Non-Small-Cell Lung Cancer Drug Market
Northwest Biotherapeutics, Inc. - Northwest Biotherapeutics Prices Its Intended Placement of Shares with Foreign Institutional Investors
Novagali Pharma - Novagali Pharma Strengthens its Executive Management
Obesity - Fda Advisory Committee Did Not Recommend Approval of Rimonabant (zimulti) for Use In Obese and Overweight Patients With Associated Risks Factors
Obesity and Diabetes - Amylin Pharmaceuticals to Present New Data from Broad Diabetes and Obesity Programs at ADA 2007
Obesity and Diabetes - Genaera to Present Preclinical Data on Trodusquemine for the Treatment of Obesity at the American Diabetes Association 67th Scientific Sessions
Obesity and Diabetes - New study shows that telmisartan has greater renoprotective potential than losartan in hypertensive patients with type 2 diabetes
Obesity and Diabetes - OREXIGEN Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
Obesity and Diabetes - VIVUS Completes End of Phase 2 Meeting with the FDA for Qnexa, a Treatment for Obesity
Oncology - Dr. Keith Elliston, Genstruct's CEO to Present at Beyond Genome's Applying Systems Biology Conference
Oncology - FDA Grants Priority Review for Bristol-Myers Squibb's Investigational Oncology Treatment Ixabepilone
Oncology - Vegenics Licenses From CoGenesys Antibodies Against VEGF-C for Applications Including Oncology
Physiology - Nobel Prize Winning Scientist Joins InVivo Therapeutics Team
Pneumonia - Accelr8 Announces Reduced Losses, and Presentation of Results for Rapid MRSA Identification at ASM's 107th General Meeting
Pneumonia - Arpida Receives Approval From US FDA to Initiate a Phase II Trial With iclaprim in Hospital-Acquired, Ventilator and Healthcare-Associated Pneumonia
Polio - GlaxoSmithKline's application for DTaP-IPV vaccine is accepted for review by the FDA
POZEN Inc. - POZEN to Present at the Jefferies 2007 Healthcare Conference
Pre-Trials Research - Gamma Medica-Ideas Introduces High Resolution CT Subsystem
Pre-Trials Research - Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin Technology
Prime Therapeutics - Prime Therapeutics Announces Participation in URAC Accreditation
Regulatory Actions - FDA Converts TELCYTA Full Clinical Hold to Partial Hold
Regulatory Actions - FDA Issues Third Approvable Letter for Thelin (Sitaxsentan Sodium)
Regulatory Actions - Gain Insight Into the Pharmaceutical Market in Slovakia
Regulatory Actions - Gilead Sciences to Host Conference Call to Discuss the U.S. Food and Drug Administration Approval of Letairis
Regulatory Actions - GSA/HHS/FDA Dedicate New Engineering and Physics Laboratory in White Oak, Maryland
Regulatory Actions - Immucor's Echo Cleared by FDA for Marketing in U.S.
Regulatory Actions - Import of medicinal products to be sold or dispensed according to a compassionate use permit
Regulatory Actions - In 2005, the Czech Republic Spent CZK209bn (US$9.6bn) on Healthcare According to New Report Czech Republic Pharmaceuticals & Healthcare Report Q4 2006
Regulatory Actions - Labopharm's Once-Daily Tramadol Approved for Sale in Canada
